Distributions of all expression values and Top 1% of expressed Intron features for libraries: MDS019_T1, MDS019_T2, MDS019_T3
Download data matrix file (Intron x library): IntronExpression_v60.txt.gz
Distribution of log2 expression values for library: MDS019_T1 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: MDS019_T2 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Distribution of log2 expression values for library: MDS019_T3 and data type: Intron
Distribution of all expression values for the feature type: Intron. Note that unlike in the individual gene pages these log2 expression values were not adjusted by adding 1 before converting to log2 scale. This results in -ve expression values if the average coverage of the feature was less than 1 before conversion to log2 scale. The 95th percentile of Silent Intergenic regions is reported to give an indication of the level of background expression noise. *If you can not see the figure below, click here
Top 1% of expressed Intron features
The following table provides a ranked list of the most highly expressed Intron features. Each column corresponds to an expression library. Each table cell contains the Gene Name (which links to the ALEXA-Seq gene record), followed by the Feature Name (which links to the feature's coordinates in the UCSC Genome Browser and displays expression data), the log2 expression value 'Exp' for the feature, and the percent expression value '% Exp' ([feature expression/gene expression]*100). For Gene records the percent displayed here represents the percentage of all reads for the library instead. Features that are NOT supported by an EST/mRNA sequence are indicated in bold. For exon junction features the number of exons skipped by the junction is indicated as 'Sn', where n is the number of exons skipped (e.g. S0 means no exons skipped, S1 means one exon skipped, etc.).
| RANK | MDS019_T1 (Gene | Feature | Exp | % Exp) | MDS019_T2 (Gene | Feature | Exp | % Exp) | MDS019_T3 (Gene | Feature | Exp | % Exp) |
| 1 | SOD2 | I5 | 9.14 | 179.48% | AP000944.1 | I1 | 9.51 | 79.21% | ADRM1 | I5 | 9.86 | 89.71% |
| 2 | H2AFX | I1 | 8.85 | 69.44% | DDX5 | I12 | 9.35 | 23.15% | H2AFX | I1 | 9.24 | 77.34% |
| 3 | AC104597.1 | I1 | 8.54 | 4648.72% | ACADVL | I10 | 9.21 | 54.80% | AC104597.1 | I1 | 9.14 | 30480.31% |
| 4 | AP000944.1 | I1 | 8.47 | 71.25% | FOSB | I1 | 9.08 | 85.45% | MOBKL1B | I9 | 8.83 | 126.29% |
| 5 | MOBKL1B | I9 | 8.35 | 123.83% | AC104597.1 | I1 | 8.91 | 2640.82% | SOD2 | I5 | 8.64 | 169.47% |
| 6 | KIF2A | I24 | 8.24 | 90.57% | HNRNPH1 | I5 | 8.75 | 56.80% | AC012652.2 | I4 | 8.26 | 128.10% |
| 7 | HNRNPH1 | I5 | 8.06 | 44.46% | AP000944.1 | I2 | 8.57 | 41.08% | POU4F1 RP11-52L5.4 | Ix | 8.24 | 57.05% |
| 8 | AC012652.2 | I4 | 8.01 | 117.38% | RP4-781K5.2 IRF2BP2 | Ix | 8.49 | 48.99% | NCLP1 SNHG7 | Ix | 8.12 | 1367.80% |
| 9 | KHSRP | I20 | 7.98 | 49.93% | RP4-781K5.2 IRF2BP2 | Ix | 8.47 | 48.36% | C11orf48 | I4 | 8.01 | 43.20% |
| 10 | SNRPD3 | I4 | 7.82 | 20.23% | HNRNPH1 | I4 | 8.24 | 40.09% | RNF167 | I1 | 7.91 | 39.56% |
| 11 | FOSB | I1 | 7.81 | 39.35% | H2AFX | I1 | 8.18 | 57.05% | KIF2A | I24 | 7.87 | 94.75% |
| 12 | SLC25A15 | I8 | 7.80 | 126.63% | SOD2 | I5 | 8.05 | 110.94% | RP11-149B7.3 | I1 | 7.71 | 51.92% |
| 13 | KIF22 | I11 | 7.78 | 60.46% | AL136219.2 RP11-149B7.3 | Ix | 8.03 | 75.64% | KHSRP | I20 | 7.62 | 47.75% |
| 14 | SFPQ | I10 | 7.76 | 28.77% | SFPQ | I10 | 7.94 | 36.48% | PAFAH1B2 | I6 | 7.58 | 98.09% |
| 15 | SFPQ | I9 | 7.70 | 27.63% | KHSRP | I20 | 7.93 | 51.65% | CHD8 | I2 | 7.47 | 140.01% |
| 16 | RP11-149B7.3 | I1 | 7.66 | 57.80% | RP11-814P23.1 RP11-472B18.2 | Ix | 7.88 | 309.39% | PAG1 | I9 | 7.42 | 86.07% |
| 17 | AB019439.3 | I4 | 7.52 | 270.23% | SRRM2 | I13 | 7.85 | 21.21% | AL136219.2 RP11-149B7.3 | Ix | 7.34 | 40.25% |
| 18 | AL031670.1 | I1 | 7.50 | 116.24% | CALCOCO2 | I19 | 7.79 | 76.38% | NDE1 | I11 | 7.27 | 99.02% |
| 19 | C14orf45 | I18 | 7.50 | 1733.16% | NAALADL1 | I10 | 7.79 | 368.82% | TSPAN16 | I6 | 7.06 | 2084.42% |
| 20 | ZNF28 ZNF160 | Ix | 7.49 | 309.94% | PPIL3 CLK1 | Ix | 7.76 | 118.04% | DIMT1L KIF2A | Ix | 6.96 | 50.35% |
| 21 | AL136219.2 RP11-149B7.3 | Ix | 7.49 | 51.33% | HNRNPH1 | I3 | 7.75 | 28.49% | PTPN1 | I9 | 6.94 | 33.88% |
| 22 | AC112504.1 AC133435.2 | Ix | 7.45 | 102.56% | AL031670.1 | I1 | 7.73 | 115.90% | TIPRL | I8 | 6.85 | 41.80% |
| 23 | OVOL2 SNX5 | Ix | 7.42 | 122.41% | AC012652.2 | I4 | 7.73 | 125.46% | MED1 | I17 | 6.82 | 65.11% |
| 24 | CHD8 | I2 | 7.39 | 122.77% | LAIR1 | I1 | 7.70 | 29.15% | RP11-25K19.1 | I2 | 6.78 | 54.18% |
| 25 | NAALADL1 | I10 | 7.34 | 270.83% | KIF22 | I11 | 7.69 | 70.48% | AC007620.3 | I1 | 6.75 | 71.55% |
| 26 | RP11-1148L6.5 | I1 | 7.31 | 184.20% | EWSR1 | I9 | 7.68 | 35.66% | VPRBP | I28 | 6.62 | 120.34% |
| 27 | NCLP1 SNHG7 | Ix | 7.30 | 569.57% | SFPQ | I9 | 7.67 | 30.30% | C14orf45 | I18 | 6.60 | 2194.00% |
| 28 | C9orf43 | I10 | 7.27 | 364.69% | CHD8 | I2 | 7.67 | 138.42% | ERLIN2 | I2 | 6.58 | 75.16% |
| 29 | AP000944.1 | I2 | 7.23 | 30.01% | MOBKL1B | I9 | 7.66 | 101.22% | AL031670.1 | I1 | 6.58 | 104.54% |
| 30 | SF1 | I5 | 7.16 | 22.60% | NXF1 | I10 | 7.62 | 31.59% | CALCOCO2 | I19 | 6.58 | 25.30% |
| 31 | C11orf48 | I4 | 7.15 | 32.22% | EPHX1 RP11-285F7.2 | Ix | 7.59 | 227.34% | SCN2A | I11 | 6.56 | 235.84% |
| 32 | HNRNPH1 | I4 | 7.10 | 22.70% | KIF2A | I24 | 7.58 | 85.48% | SLC12A6 | I2 | 6.55 | 29.51% |
| 33 | PAFAH1B2 | I6 | 7.06 | 84.03% | CUL4B | I5 | 7.57 | 181.29% | PRKRA AC009948.5 | Ix | 6.53 | 64.21% |
| 34 | ILF3 | I11 | 7.01 | 25.26% | AC112504.1 AC133435.2 | Ix | 7.55 | 161.40% | ARG2 | I7 | 6.52 | 231.28% |
| 35 | MBD5 ORC4L | Ix | 7.00 | 132.50% | SEPT6 | I14 | 7.52 | 27.33% | DGKZ | I29 | 6.52 | 54.14% |
| 36 | RNF167 | I1 | 6.97 | 23.15% | MAN2B1 | I7 | 7.51 | 29.26% | CNOT7 | I11 | 6.52 | 43.63% |
| 37 | DIMT1L KIF2A | Ix | 6.95 | 36.90% | RP11-10K16.1 | I1 | 7.47 | 1339.05% | CELF1 | I15 | 6.50 | 106.06% |
| 38 | RALBP1 | I4 | 6.94 | 52.58% | PRKRA AC009948.5 | Ix | 7.45 | 116.15% | FAM65B | I16 | 6.45 | 42.08% |
| 39 | AVP | I1 | 6.93 | 361.64% | SFPQ | I11 | 7.45 | 25.90% | PRKRA AC009948.5 | Ix | 6.45 | 60.73% |
| 40 | AC007620.3 | I1 | 6.92 | 75.32% | SCN3A | I28 | 7.41 | 40.77% | RP11-1148L6.5 | I1 | 6.42 | 158.21% |
| 41 | SFRS7 | I5 | 6.88 | 25.71% | RP11-149B7.3 | I1 | 7.40 | 48.76% | C19orf54 | I1 | 6.38 | 158.86% |
| 42 | RP3-327A19.5 | I1 | 6.87 | 532.19% | CDK5RAP3 | I7 | 7.40 | 31.58% | CUL4B | I5 | 6.38 | 67.55% |
| 43 | MED1 | I17 | 6.86 | 65.82% | LDB1 | I11 | 7.39 | 41.25% | AC093673.5 | I1 | 6.36 | 103.23% |
| 44 | MAP7 | I2 | 6.85 | 50.25% | ACIN1 | I10 | 7.39 | 46.98% | KIAA0391 | I1 | 6.35 | 53.63% |
| 45 | ZFAND5 | I4 | 6.83 | 49.46% | ACAP1 | I17 | 7.39 | 44.17% | PDK1 | I15 | 6.34 | 80.89% |
| 46 | LDB1 | I11 | 6.82 | 24.06% | SF1 | I3 | 7.38 | 26.22% | TFIP11 | I15 | 6.34 | 71.35% |
| 47 | KIAA0391 | I1 | 6.78 | 56.40% | YPEL5 | I4 | 7.37 | 57.73% | PADI4 | I15 | 6.30 | 247.70% |
| 48 | CELF1 | I15 | 6.77 | 102.64% | TRIM56 | I3 | 7.36 | 204.73% | H2AFV | I5 | 6.29 | 20.23% |
| 49 | EWSR1 | I9 | 6.76 | 20.93% | TSPYL2 | I1 | 7.35 | 62.61% | DLC1 | I21 | 6.27 | 163.83% |
| 50 | YPEL5 | I4 | 6.76 | 37.50% | PSME2 | I2 | 7.35 | 29.65% | CSNK2A2 | I11 | 6.20 | 60.98% |
| 51 | TFIP11 | I15 | 6.75 | 119.74% | SFRS7 | I5 | 7.34 | 42.68% | INF2 | I19 | 6.19 | 111.54% |
| 52 | H2AFV | I5 | 6.74 | 22.42% | TSC22D3 | I8 | 7.32 | 25.44% | MFSD11 | I1 | 6.17 | 67.06% |
| 53 | C19orf54 | I1 | 6.63 | 166.79% | FOSB | I3 | 7.32 | 25.27% | SFRS18 | I3 | 6.17 | 86.15% |
| 54 | TOP3A AC087164.1 | Ix | 6.61 | 105.08% | FBXW7 | I12 | 7.31 | 35.13% | LNX1 FIP1L1 | Ix | 6.16 | 78.66% |
| 55 | SLC25A15 | I8 | 6.61 | 55.25% | C14orf45 | I18 | 7.31 | 3290.86% | MALAT1 | I1 | 6.16 | 20.92% |
| 56 | AC034193.5 | I1 | 6.59 | 143.50% | ILF3 | I11 | 7.29 | 32.09% | FUBP1 | I22 | 6.14 | 22.99% |
| 57 | CSNK2A2 | I11 | 6.56 | 72.78% | DUSP10 | I2 | 7.29 | 36.35% | AB019439.3 | I6 | 6.14 | 667.85% |
| 58 | CD3EAP | I2 | 6.56 | 138.36% | ZNF28 ZNF160 | Ix | 7.28 | 265.67% | SYVN1 | I2 | 6.10 | 41.42% |
| 59 | TRA2B | I3 | 6.55 | 26.04% | ORMDL1 | I1 | 7.27 | 141.00% | FANCL | I12 | 6.10 | 60.01% |
| 60 | PPIL3 CLK1 | Ix | 6.53 | 75.25% | SNRNP70 | I8 | 7.25 | 31.63% | TP53BP1 | I30 | 6.10 | 100.78% |
| 61 | BTN3A2 | I11 | 6.53 | 65.37% | SPTBN1 | I34 | 7.22 | 69.64% | RASSF1 | I2 | 6.09 | 50.65% |
| 62 | NDE1 | I11 | 6.52 | 88.80% | SDR39U1 | I1 | 7.21 | 40.59% | PRDM8 | I12 | 6.06 | 115.49% |
| 63 | FNBP1 | I23 | 6.49 | 29.43% | VIM RP11-124N14.3 | Ix | 7.20 | 20.84% | TP53BP1 | I32 | 6.03 | 96.15% |
| 64 | PTPN1 | I9 | 6.47 | 33.22% | CD27 | I4 | 7.19 | 321.91% | EIF2AK4 | I38 | 6.00 | 38.50% |
| 65 | AB019439.3 | I2 | 6.45 | 127.89% | C13orf15 | I3 | 7.18 | 161.71% | TRIM56 | I3 | 5.96 | 195.41% |
| 66 | ARG2 | I7 | 6.43 | 188.53% | NCRNA00201 HNRNPU | Ix | 7.18 | 25.86% | FBXW2 | I7 | 5.96 | 68.65% |
| 67 | TRIM56 | I3 | 6.42 | 174.67% | CD97 | I13 | 7.18 | 36.77% | SLC25A15 | I8 | 5.96 | 134.89% |
| 68 | CCNL1 | I3 | 6.41 | 55.15% | EPHX1 RP11-285F7.2 | Ix | 7.17 | 170.16% | RP11-10K16.1 | I1 | 5.94 | 446.22% |
| 69 | C16orf72 | I3 | 6.41 | 209.39% | ATG16L2 | I3 | 7.15 | 98.24% | OVOL2 SNX5 | Ix | 5.89 | 57.06% |
| 70 | DPPA4 | I3 | 6.39 | 33.49% | CCR2 | I3 | 7.13 | 89.27% | MBD1 | I18 | 5.84 | 42.59% |
| 71 | MBD1 | I18 | 6.38 | 61.43% | AC007620.3 | I1 | 7.09 | 69.60% | TOP3A AC087164.1 | Ix | 5.84 | 85.00% |
| 72 | AC005332.2 | I1 | 6.38 | 59.04% | EIF4A2 | I1 | 7.09 | 22.08% | OFD1 | I18 | 5.83 | 26.03% |
| 73 | C10orf2 | I2 | 6.37 | 88.92% | ARPC2 | I6 | 7.09 | 24.89% | MPHOSPH9 | I21 | 5.80 | 42.59% |
| 74 | PPIL3 CLK1 | Ix | 6.36 | 66.74% | NAA40 | I2 | 7.08 | 121.54% | LUC7L2 | I12 | 5.79 | 26.85% |
| 75 | RBM15 | I2 | 6.34 | 131.80% | MBD5 ORC4L | Ix | 7.08 | 170.65% | CTC-458I2.2 SERINC5 | Ix | 5.79 | 268.70% |
| 76 | VPRBP | I28 | 6.33 | 99.85% | SF1 | I5 | 7.07 | 21.15% | AB019439.3 | I2 | 5.77 | 514.40% |
| 77 | FUBP1 | I22 | 6.33 | 29.10% | RP11-1148L6.5 | I1 | 7.05 | 192.86% | C16orf72 | I3 | 5.75 | 111.06% |
| 78 | TIPRL | I8 | 6.31 | 39.57% | RNF167 | I1 | 7.04 | 20.96% | CTC-205M6.2 | I1 | 5.75 | 60.88% |
| 79 | TP53BP1 | I30 | 6.30 | 86.31% | KIAA0391 | I1 | 7.02 | 57.88% | RP11-27I1.2 | I1 | 5.75 | 116.96% |
| 80 | PAG1 | I9 | 6.27 | 91.82% | PPIL3 CLK1 | Ix | 7.02 | 70.55% | BTN3A2 | I11 | 5.74 | 60.02% |
| 81 | TMEM111 AC034193.5 | Ix | 6.27 | 84.51% | DEXI | I2 | 7.01 | 255.25% | AC093484.6 | I1 | 5.65 | 158.76% |
| 82 | CD27 | I4 | 6.24 | 310.88% | AB019439.3 | I6 | 7.00 | 185.97% | TP53BP1 | I31 | 5.63 | 72.53% |
| 83 | ANKRD10 RP11-120J20.2 | Ix | 6.23 | 69.81% | SYNGAP1 AL662799.2 | Ix | 7.00 | 115.19% | ZNF28 ZNF160 | Ix | 5.63 | 136.74% |
| 84 | RP11-291L15.2 HHIP | Ix | 6.22 | 108.75% | PAG1 | I9 | 7.00 | 70.06% | FUT11 | I5 | 5.62 | 110.17% |
| 85 | CNOT7 | I11 | 6.20 | 42.72% | ANKRD10 RP11-120J20.2 | Ix | 6.98 | 83.20% | AAK1 AC114772.2 | Ix | 5.62 | 96.09% |
| 86 | TP53BP1 | I32 | 6.18 | 79.54% | MALAT1 | I1 | 6.98 | 20.76% | C10orf2 | I2 | 5.60 | 98.14% |
| 87 | SPTBN1 | I34 | 6.18 | 45.55% | RNASET2 RP11-514O12.4 | Ix | 6.90 | 89.16% | ORMDL1 | I1 | 5.60 | 40.73% |
| 88 | AC040975.1 HMBOX1 | Ix | 6.16 | 99.58% | DGKZ | I29 | 6.89 | 54.78% | MSL1 | I3 | 5.58 | 25.11% |
| 89 | SNHG3 RCC1 | Ix | 6.14 | 22.05% | EPHX1 RP11-285F7.2 | Ix | 6.88 | 139.22% | RP11-262H14.1 | I1 | 5.57 | 240.90% |
| 90 | ACIN1 | I10 | 6.14 | 23.03% | C19orf54 | I1 | 6.88 | 168.39% | FOSB | I1 | 5.57 | 24.27% |
| 91 | AB019439.3 | I6 | 6.13 | 102.46% | HDC | I7 | 6.87 | 49.25% | ZNF589 | I7 | 5.56 | 927.56% |
| 92 | MICAL2 | I26 | 6.12 | 134.43% | U66061.31 | I5 | 6.86 | 40.22% | EPHX1 RP11-285F7.2 | Ix | 5.55 | 55.15% |
| 93 | MICAL2 | I27 | 6.12 | 134.38% | BTN3A2 | I11 | 6.85 | 57.05% | AC023024.2 | I6 | 5.54 | 66.62% |
| 94 | BCL11A | I3 | 6.12 | 40.72% | SYNGAP1 AL662799.2 | Ix | 6.84 | 102.80% | TCF19 | I1 | 5.52 | 22.83% |
| 95 | RBM39 | I16 | 6.11 | 25.35% | BAT2L | I29 | 6.83 | 45.91% | NCLP1 SNHG7 | Ix | 5.51 | 220.50% |
| 96 | ANKRD10 | I9 | 6.11 | 64.23% | LETMD1 | I1 | 6.82 | 45.42% | C17orf90 | I1 | 5.50 | 35.16% |
| 97 | RASSF1 | I2 | 6.10 | 41.60% | MICAL1 | I7 | 6.80 | 60.33% | CD3EAP | I2 | 5.48 | 89.24% |
| 98 | NCLP1 SNHG7 | Ix | 6.08 | 242.14% | SHANK3 AC000036.5 | Ix | 6.80 | 217.80% | DPP3 AP002748.3 | Ix | 5.48 | 46.14% |
| 99 | MPHOSPH9 | I21 | 6.08 | 48.82% | RASSF1 | I3 | 6.79 | 59.48% | AL592183.4 | I7 | 5.48 | 37.33% |
| 100 | LETMD1 | I1 | 6.06 | 43.23% | FBXW7 | I10 | 6.77 | 24.05% | SLC25A35 RANGRF | Ix | 5.48 | 33.44% |